Biote (BTMD) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BTMD Biote Corp BTMD
72 GF Score
Price $2.19
GF Value $3.07
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Biote Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BTMD
72GF Score
Biote Corp BTMD
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biote (BTMD) Overvalued in 2026?

Based on GuruFocus' analysis, Biote stock appears to be undervalued. The current stock price of $2.19 is trading 28.7% below its estimated GF Value™ of $3.07. GuruFocus considers Biote to be Modestly Undervalued.

Key valuation signals for BTMD:

  • Short Ratio:
  • GF Value™: $3.07 vs. price of $2.19 (28.7% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the BTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biote Business Description

Address 1875 W. Walnut Hill Lane, Suite 100, Irving, TX, USA, 75038
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
72GF Score

Get the complete analysis for BTMD

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.19
Price
$3.07
GF Value